DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mozobil (Plerixafor Subcutaneous) - Therapeutic Response Decreased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Therapeutic Response Decreased (10)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mozobil (Plerixafor Subcutaneous) where reactions include therapeutic response decreased. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Mozobil side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-09

Patient: female, weighing 44.0 kg (96.8 pounds)

Reactions: Therapeutic Response Decreased, Pleural Effusion, Lobar Pneumonia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Meropenem; Etoposide; Cytarabine; Acetaminophen; Morphine Sulfate; Ondansetron; Vancomycin; Solutions FOR Parenteral Nutrition



Possible Mozobil side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24

Patient: female

Reactions: Therapeutic Response Decreased, Pleural Effusion, Lobar Pneumonia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Cytarabine; Morphine Sulfate; Ondansetron; Etoposide; Solutions FOR Parenteral Nutrition; Vancomycin; Acetaminophen; Meropenem



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female

Reactions: Therapeutic Response Decreased, Pleural Effusion, Lobar Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Cytarabine; Meropenem; Ondansetron; Vancomycin; Etoposide; Acetaminophen; Morphine Sulfate; Solutions FOR Parenteral Nutrition



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-06-01

Patient: female, weighing 73.8 kg (162.4 pounds)

Reactions: Death, Therapeutic Response Decreased, Upper Respiratory Tract Infection, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-13
    End date: 2011-01-13

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-16
    End date: 2011-01-16

Bortezomib
    Dosage: 1.3 mg/m2, once
    Indication: Multiple Myeloma
    Start date: 2011-01-06
    End date: 2011-01-06

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-02-06
    End date: 2011-02-06

Mozobil
    Dosage: 320 mcg/kg, once
    Indication: Multiple Myeloma
    Start date: 2011-01-09
    End date: 2011-01-09

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-09
    End date: 2011-01-09

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-13
    End date: 2011-01-13

Mozobil
    Dosage: 320 mcg/kg, qd
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2011-01-04
    End date: 2011-01-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-16
    End date: 2011-01-16

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-02-06
    End date: 2011-02-06

Other drugs received by patient: Advair Diskus 100 / 50; Norvasc; Albuterol; Zithromax



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-05-11

Patient: female, weighing 73.8 kg (162.4 pounds)

Reactions: Death, Therapeutic Response Decreased, Upper Respiratory Tract Infection, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-02-06
    End date: 2011-02-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Indication: Multiple Myeloma
    Start date: 2011-01-06
    End date: 2011-01-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-02-06
    End date: 2011-02-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-13
    End date: 2011-01-13

Mozobil
    Dosage: 320 mcg/kg, qd
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2011-01-04
    End date: 2011-01-06

Mozobil
    Dosage: 320 mcg/kg, once
    Indication: Multiple Myeloma
    Start date: 2011-01-09
    End date: 2011-01-09

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-16
    End date: 2011-01-16

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-16
    End date: 2011-01-16

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-13
    End date: 2011-01-13

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-09
    End date: 2011-01-09

Other drugs received by patient: Albuterol; Norvasc; Zithromax; Advair Diskus 100 / 50



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-04-19

Patient: female, weighing 73.8 kg (162.4 pounds)

Reactions: Death, Therapeutic Response Decreased, Upper Respiratory Tract Infection, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-02-06
    End date: 2011-02-06

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-16
    End date: 2011-01-16

Bortezomib
    Dosage: 1.3 mg/m2, once
    Indication: Multiple Myeloma
    Start date: 2011-01-06
    End date: 2011-01-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-16
    End date: 2011-01-16

Mozobil
    Dosage: 320 mcg/kg, once
    Indication: Multiple Myeloma
    Start date: 2011-01-09
    End date: 2011-01-09

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-13
    End date: 2011-01-13

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-13
    End date: 2011-01-13

Mozobil
    Dosage: 320 mcg/kg, qd
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2011-01-04
    End date: 2011-01-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-09
    End date: 2011-01-09

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-02-06
    End date: 2011-02-06

Other drugs received by patient: Albuterol; Norvasc; Advair Diskus 100 / 50; Zithromax



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-04-13

Patient: female, weighing 73.8 kg (162.4 pounds)

Reactions: Therapeutic Response Decreased, Upper Respiratory Tract Infection, Influenza

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-02-06
    End date: 2011-02-06

Mozobil
    Dosage: 320 mcg/kg, once
    Indication: Multiple Myeloma
    Start date: 2011-01-09
    End date: 2011-01-09

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-09
    End date: 2011-01-09

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-16
    End date: 2011-01-16

Bortezomib
    Dosage: 1.3 mg/m2, once
    Indication: Multiple Myeloma
    Start date: 2011-01-06
    End date: 2011-01-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-13
    End date: 2011-01-13

Mozobil
    Dosage: 320 mcg/kg, qd
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2011-01-04
    End date: 2011-01-06

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-13
    End date: 2011-01-13

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-02-06
    End date: 2011-02-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-16
    End date: 2011-01-16

Other drugs received by patient: Zithromax; Advair Diskus 100 / 50; Norvasc; Albuterol



Possible Mozobil side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-08

Patient:

Reactions: Therapeutic Response Decreased, Pulmonary Embolism, Deep Vein Thrombosis

Drug(s) suspected as cause:
Mozobil
    Indication: non-Hodgkin's Lymphoma

Mozobil
    Indication: Haematopoietic Stem Cell Mobilisation



Possible Mozobil side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-02

Patient:

Reactions: Therapeutic Response Decreased, Sepsis

Drug(s) suspected as cause:
Mozobil
    Indication: Multiple Myeloma

Mozobil
    Dosage: unk
    Indication: Haematopoietic Stem Cell Mobilisation



Possible Mozobil side effects in

Reported by a physician from United Kingdom on 2012-02-02

Patient:

Reactions: Therapeutic Response Decreased, Pulmonary Embolism, Deep Vein Thrombosis

Drug(s) suspected as cause:
Mozobil
    Indication: non-Hodgkin's Lymphoma

Mozobil
    Indication: Haematopoietic Stem Cell Mobilisation

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017